other material
confidence high
sentiment neutral
materiality 0.45
Bionomics enters $2M ATM offering with H.C. Wainwright, replaces prior $11.5M program
Neuphoria Therapeutics Inc.
- Signed ATM agreement with H.C. Wainwright for up to $2 million in ADSs; 3.0% sales commission.
- Prior $11.5M ATM program with Cantor Fitzgerald terminated before signing new agreement.
- Shelf registration on Form S-3 filed Nov 18, 2024 (File No. 333-283306) for the offering.
- Sales agent may sell ADSs on Nasdaq at market prices; no minimum required sales.